Osilodrostat
Osilodrostat is a pharmaceutical drug with 10 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
2
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
Clinical Trials (10)
Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function
A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function
Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10